Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
EVOK holding history
Evoke Pharma Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVOK overviewAll 13F holders of EVOKFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −12,542−100.0% | Sold out | Holders |
| Q2 2025 | 12,542 | $33.0K | <0.1% | −12,261−49.4% | Reduced | Holders |
| Q1 2025 | 24,803 | $68.2K | <0.1% | +24,803 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −993−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q2 2024 | 11,911 | $6.30K | <0.1% | +11,911 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −26,592−100.0% | Sold out | Holders |
| Q4 2021 | 26,592 | $15.0K | <0.1% | −13,177−33.1% | Reduced | Holders |
| Q3 2021 | 39,769 | $52.0K | <0.1% | +640+1.6% | Added | Holders |
| Q2 2021 | 39,129 | $54.0K | <0.1% | +39,129 | New | Holders |